SHL Medical participates in the CPHI Frankfurt 2022
SHL Medical is excited to announce our participation for the first time ever in the 2022 CPHI Frankfurt. SHL will be exhibiting at Booth #30A30 on November 1-3 in Frankfurt, Germany.
SHL’s participation in CPHI Frankfurt 2022 – one of the biggest international pharma industry events – is critical in supporting the growth of our community and unlocking new business opportunities via meaningful connections.
With years of experience under our belt, SHL stands to our commitment in reshaping the drug delivery industry through groundbreaking autoinjector innovations. “Part of the reason behind our success is the long-standing experience working with our partners,” SHL Marketing Director Magnus Fastmarken said. “As SHL Medical evolves, we look to collaborate with world-class bio/pharmaceutical companies that share our vision in developing innovative self-treatment therapies to improve the quality of life of patients.”
SHL’s professional teams will be onsite during the live event to share their knowledge and experiences as well as to introduce the company’s comprehensive portfolio. Visitors can rely on SHL’s expertise to provide them with quality solutions that will suit their needs, from effective device solutions such as Molly® and Maggie® autoinjectors, extensive manufacturing capabilities, to adept digital health initiatives.
We are also excited to announce that both our modular Fully Automated Testing Machine (FATM) platform and our Maggie 5.0 autoinjector have been shortlisted as winning candidates for the CPHI Pharma Awards 2022. The award seeks to recognize “Excellence in Pharma”, assessing entries from industry’s leading companies in pursuit of innovation in various categories.
In addition to the in-person event, CPHI Frankfurt 2022 will also take place online. Visitors can visit SHL’s online platform to check our portfolio.
Register today to get your early access.
Where: Messe, Frankfurt, Germany | Booth #30A30
When: November 1-3
